CN117004036A - A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application - Google Patents
A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application Download PDFInfo
- Publication number
- CN117004036A CN117004036A CN202310986434.2A CN202310986434A CN117004036A CN 117004036 A CN117004036 A CN 117004036A CN 202310986434 A CN202310986434 A CN 202310986434A CN 117004036 A CN117004036 A CN 117004036A
- Authority
- CN
- China
- Prior art keywords
- quaternary ammonium
- ammonium salt
- hyperbranched polylysine
- polylysine
- hyperbranched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/005—Hyperbranched macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G85/00—General processes for preparing compounds provided for in this subclass
- C08G85/006—Scale prevention in polymerisation reactors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Polyamides (AREA)
Abstract
本发明提供了一种超支化聚赖氨酸季铵盐及其制备方法和应用,具体的,所述超支化聚赖氨酸季铵盐具有式Ⅰ或II所示结构。本发明对超支化聚赖氨酸进行季铵化或通过赖氨酸季铵盐与赖氨酸共聚获得超支化聚赖氨酸季铵盐,不但可有效抑制多重耐药革兰氏阴性菌,杀菌动力学结果显示其杀菌速率显著提高,且具有较好的抗病毒效果。
The invention provides a hyperbranched polylysine quaternary ammonium salt and its preparation method and application. Specifically, the hyperbranched polylysine quaternary ammonium salt has a structure shown in formula I or II. The present invention quaternizes hyperbranched polylysine or obtains hyperbranched polylysine quaternary ammonium salt by copolymerizing lysine quaternary ammonium salt and lysine, which can not only effectively inhibit multi-drug resistant Gram-negative bacteria, The sterilization kinetics results show that the sterilization rate is significantly improved and it has good antiviral effect.
Description
技术领域Technical Field
本发明涉及抗菌材料技术领域,尤其涉及一种超支化聚赖氨酸季铵盐及其制备方法和应用。The invention relates to the technical field of antibacterial materials, and in particular to a hyperbranched polylysine quaternary ammonium salt and a preparation method and application thereof.
背景技术Background Art
近年来,随着多种细菌尤其是多重耐药菌的逐渐出现,对人类健康产生了极其严重的威胁。In recent years, with the gradual emergence of various bacteria, especially multidrug-resistant bacteria, it has posed an extremely serious threat to human health.
根据抗菌方式的不同,目前的抗菌剂主要分为释放型抗菌剂和接触型抗菌剂,释放型抗菌剂主要包括无机和有机小分子抗菌剂,接触型抗菌剂主要包括高分子抗菌剂。由于高分子抗菌剂是基于接触过程而不是活性物质的释放来抗菌,所以抗菌性能稳定,效果持久,且使用安全性大大提高。这使其备受青睐,近年来发展迅速。According to the different antibacterial methods, the current antibacterial agents are mainly divided into release-type antibacterial agents and contact-type antibacterial agents. Release-type antibacterial agents mainly include inorganic and organic small molecule antibacterial agents, and contact-type antibacterial agents mainly include polymer antibacterial agents. Since polymer antibacterial agents are based on the contact process rather than the release of active substances to fight bacteria, they have stable antibacterial properties, long-lasting effects, and greatly improved safety of use. This makes them very popular and has developed rapidly in recent years.
高分子抗菌剂主要包括抗菌肽类抗菌剂、季铵盐类抗菌剂等。抗菌肽主要通过物理手段杀死致病菌,降低了产生耐药性的可能,与其结构相似的抗菌肽模拟物成为目前抗菌肽开发的重点方向。季铵盐类抗菌材料属于一种聚阳离子抗菌剂,因其广谱抗菌、抗病毒性被广泛研究并应用。Polymeric antimicrobial agents mainly include antimicrobial peptide antimicrobial agents, quaternary ammonium salt antimicrobial agents, etc. Antimicrobial peptides mainly kill pathogenic bacteria by physical means, reducing the possibility of drug resistance. Antimicrobial peptide mimetics with similar structures have become the focus of antimicrobial peptide development. Quaternary ammonium salt antimicrobial materials are a type of polycationic antimicrobial agent, which has been widely studied and applied due to its broad-spectrum antibacterial and antiviral properties.
但是,目前鲜有聚合物类抗菌材料以及季铵盐类抗菌材料能够表现出对于多重耐药的革兰氏阴性菌的抗菌性能。超支化聚赖氨酸具有广谱抗菌性能,但其也不具备抗多重耐药革兰氏阴性菌性能及抗病毒性能。开发能够对抗多重耐药菌感染的新型抗菌药物成为亟待解决的问题。However, there are currently few polymer antibacterial materials and quaternary ammonium salt antibacterial materials that can show antibacterial properties against multi-drug resistant Gram-negative bacteria. Hyperbranched polylysine has broad-spectrum antibacterial properties, but it also does not have anti-multi-drug resistant Gram-negative bacteria properties and antiviral properties. The development of new antibacterial drugs that can fight multi-drug resistant bacterial infections has become an urgent problem to be solved.
发明内容Summary of the invention
有鉴于此,本发明要解决的技术问题在于提供一种超支化聚赖氨酸季铵盐及其制备方法和应用,所述超支化聚赖氨酸季铵盐可有效抑制多重耐药革兰氏阴性菌。In view of this, the technical problem to be solved by the present invention is to provide a hyperbranched polylysine quaternary ammonium salt and a preparation method and application thereof, wherein the hyperbranched polylysine quaternary ammonium salt can effectively inhibit multidrug-resistant Gram-negative bacteria.
本发明提供了一种超支化聚赖氨酸季铵盐,具有式Ⅰ或式Ⅱ所示结构:The present invention provides a hyperbranched polylysine quaternary ammonium salt having a structure shown in Formula I or Formula II:
m1、m2、m3、m4、n1、n2、x1、x2、x3、x4、y1、y2为聚合度;m 1 , m 2 , m 3 , m 4 , n 1 , n 2 , x 1 , x 2 , x 3 , x 4 , y 1 , y 2 are the degrees of polymerization;
其中,R1、R2独立的选自H或且R1、R2不同时为H;Wherein, R 1 and R 2 are independently selected from H or and R 1 and R 2 are not H at the same time;
R3、R4、R5、R6独立的选自取代或非取代的C1~C10的烷基;R 3 , R 4 , R 5 and R 6 are independently selected from substituted or unsubstituted C1-C10 alkyl groups;
a、b独立的选自0~21的整数。a and b are independently selected from integers of 0-21.
所述R3、R4、R5、R6独立的更优选为取代或非取代的C1~C6的烷基,进一步优选为取代或非取代的C1~C3的烷基。The above R 3 , R 4 , R 5 and R 6 are independently more preferably substituted or unsubstituted C1-C6 alkyl groups, and further preferably substituted or unsubstituted C1-C3 alkyl groups.
优选的,所述C1~C10的烷基的取代基选自羟基、苯基中的一种或多种。更优选为苯基。Preferably, the substituent of the C1-C10 alkyl group is selected from one or more of hydroxyl and phenyl groups, and more preferably phenyl groups.
所述C1~C6的烷基、C1~C3的烷基的取代基同上。The substituents of the C1-C6 alkyl group and the C1-C3 alkyl group are the same as above.
优选的,所述R3、R4、R5、R6独立的选自甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基或苄基。Preferably, R 3 , R 4 , R 5 and R 6 are independently selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl or benzyl.
所述a、b独立的选自0~21的整数。优选为7~15的整数,更优选为9~13的整数。The a and b are independently selected from integers of 0 to 21, preferably integers of 7 to 15, and more preferably integers of 9 to 13.
本发明中,当a为0时,表示R5、R6连接的N原子上连接有甲基。In the present invention, when a is 0, it means that a methyl group is connected to the N atom to which R 5 and R 6 are connected.
当b为0时,表示R3、R4连接的N原子上连接有甲基。When b is 0, it means that a methyl group is connected to the N atom to which R 3 and R 4 are connected.
所述超支化聚赖氨酸季铵盐的阴离子基团选自磺酸基团、羧酸基团、磷酸基团、氯离子、溴离子、碘离子的至少一种。The anion group of the hyperbranched polylysine quaternary ammonium salt is selected from at least one of a sulfonic acid group, a carboxylic acid group, a phosphoric acid group, a chloride ion, a bromide ion, and an iodide ion.
优选的,所述阴离子基团选自氯离子、溴离子、碘离子的至少一种。Preferably, the anionic group is selected from at least one of chloride ion, bromide ion and iodide ion.
式Ⅰ中,m1、m2、n1、x1、x2、y1为聚合度,m1、m2、x1、x2优选为0~60的整数,且m1、x1不同时为0,n1、y1优选为1~40的整数;且10≤m1+m2+n1+x1+x2+y1≤100,优选的,15≤m1+m2+n1+x1+x2+y1≤50;0.35≤(m1+m2)/(m1+m2+n1+x1+x2+y1)≤0.95,优选的,0.5≤(m1+m2)/(m1+m2+n1+x1+x2+y1)≤0.8。In Formula I, m1 , m2 , n1 , x1 , x2 and y1 are the degrees of polymerization, m1 , m2 , x1 and x2 are preferably integers of 0 to 60, and m1 and x1 are not 0 at the same time, and n1 and y1 are preferably integers of 1 to 40; and 10≤m1+ m2 + n1 + x1 + x2 + y1≤100 , preferably , 15≤m1+ m2 + n1 + x1 + x2 + y1≤50 ; 0.35≤( m1 +m2)/( m1 + m2 + n1 + x1 + x2 + y1 ) ≤0.95 , preferably, 0.5≤( m1 +m2)/( m1 +m2+ n1 + x1 + x2 + y1 ) ≤0 . 1 )≤0.8.
式Ⅱ中,m3、m4、n2、x3、x4、y2为聚合度,m3、m4、x3、x4优选为0~60的整数,且m3、x3不同时为0,n2、y2优选为1~40的整数;且10≤m3+m4+n2+x3+x4+y2≤100,优选的,15≤m3+m4+n2+x3+x4+y2≤50;0.35≤(m3+m4)/(m3+m4+n2+x3+x4+y2)≤0.95,优选的,0.5≤(m3+m4)/(m3+m4+n2+x3+x4+y2)≤0.8。In formula II, m3 , m4 , n2 , x3 , x4 and y2 are the degrees of polymerization, m3 , m4 , x3 and x4 are preferably integers of 0 to 60, and m3 and x3 are not 0 at the same time, n2 and y2 are preferably integers of 1 to 40; and 10≤m3+ m4 + n2 + x3 + x4 + y2≤100 , preferably , 15≤m3+ m4 + n2 + x3 + x4 + y2≤50 ; 0.35≤( m3 + m4 )/( m3 + m4 +n2+ x3 + x4 + y2 )≤0.95, preferably, 0.5≤( m3 + m4 )/( m3 + m4 + n2 + x3 + x4 + y2 ) 2 )≤0.8.
式Ⅰ或式Ⅱ中,各重复单元,可以是有序排列的,也可以是无序排列的。In formula I or II, the repeating units may be arranged in order or in disorder.
上述超支化聚赖氨酸季铵盐的季铵盐官能度优选为1%-50%,更优选为5%-25%。The quaternary ammonium salt functionality of the hyperbranched polylysine quaternary ammonium salt is preferably 1%-50%, more preferably 5%-25%.
试验结果表明可以通过调节季铵盐上碳链的长度及官能度对其抗菌性能进行调节。当碳链长度为8~16,官能度为5%-25%时,抗菌性能更为优异。本发明对上述超支化聚赖氨酸季铵盐的制备方法并无特殊限定,可以为本领域技术人员熟知的季铵化方式,包括但不限于以下两种途径:1)利用含有双键的季铵盐与超支化聚赖氨酸上的氨基通过迈克尔加成反应进行季铵化;2)对超支化聚赖氨酸上的氨基直接进行季铵化反应,得到季铵盐。The test results show that the antibacterial properties of the quaternary ammonium salt can be adjusted by adjusting the length and functionality of the carbon chain on the quaternary ammonium salt. When the carbon chain length is 8 to 16 and the functionality is 5% to 25%, the antibacterial properties are more excellent. The present invention does not specifically limit the preparation method of the hyperbranched polylysine quaternary ammonium salt, and can be a quaternization method well known to those skilled in the art, including but not limited to the following two approaches: 1) quaternization is performed by Michael addition reaction of a quaternary ammonium salt containing a double bond with an amino group on hyperbranched polylysine; 2) quaternization reaction is directly performed on the amino group on the hyperbranched polylysine to obtain a quaternary ammonium salt.
本发明制备的超支化聚赖氨酸季铵盐,可以先对赖氨酸单体进行季铵化,再利用赖氨酸季铵盐与赖氨酸共聚制备超支化聚赖氨酸季铵盐,通过调整赖氨酸季铵盐与赖氨酸的比例对超支化聚赖氨酸季铵盐的季铵化程度进行调节。The hyperbranched polylysine quaternary ammonium salt prepared by the present invention can firstly quaternize lysine monomers, and then copolymerize the lysine quaternary ammonium salt with lysine to prepare the hyperbranched polylysine quaternary ammonium salt, and the quaternization degree of the hyperbranched polylysine quaternary ammonium salt is adjusted by adjusting the ratio of the lysine quaternary ammonium salt to lysine.
具体的,本发明提供了上述超支化聚赖氨酸季铵盐的制备方法,包括以下步骤:Specifically, the present invention provides a method for preparing the hyperbranched polylysine quaternary ammonium salt, comprising the following steps:
S1)利用缩聚方法制备超支化聚赖氨酸;S1) preparing hyperbranched polylysine by a condensation polymerization method;
S2)对超支化聚赖氨酸进行季铵化处理;S2) quaternizing the hyperbranched polylysine;
或者or
SⅠ)对赖氨酸进行季铵化获得赖氨酸季铵盐;SⅠ) quaternizing lysine to obtain lysine quaternary ammonium salt;
SⅡ)利用赖氨酸季铵盐与赖氨酸进行共聚。SⅡ) Use lysine quaternary ammonium salt to copolymerize with lysine.
本发明提供了上述超支化聚赖氨酸季铵盐在制备抗菌剂中的应用。The present invention provides application of the hyperbranched polylysine quaternary ammonium salt in preparing an antibacterial agent.
优选的,所述抗菌剂为抗多重耐药革兰氏阴性菌的抗菌剂。进一步优选的,所述多重耐药革兰氏阴性菌为多重耐药大肠杆菌、多重耐药铜绿假单胞杆菌等。Preferably, the antibacterial agent is an antibacterial agent against multi-drug resistant Gram-negative bacteria. Further preferably, the multi-drug resistant Gram-negative bacteria are multi-drug resistant Escherichia coli, multi-drug resistant Pseudomonas aeruginosa, etc.
本发明提供了一种抗菌剂,包括上述超支化聚赖氨酸季铵盐。The invention provides an antibacterial agent, comprising the hyperbranched polylysine quaternary ammonium salt.
上述超支化聚赖氨酸季铵盐在浓度为12-96μg/mL时杀菌率可达到99%,具有最小抑菌浓度低,杀菌速度快的特点。The bactericidal rate of the hyperbranched polylysine quaternary ammonium salt can reach 99% when the concentration is 12-96 μg/mL, and it has the characteristics of low minimum inhibitory concentration and fast bactericidal speed.
与现有技术相比,本发明提供了一种超支化聚赖氨酸季铵盐,具有式Ⅰ或式Ⅱ所示结构。对超支化聚赖氨酸进行季铵化获得超支化聚赖氨酸季铵盐,不但可有效抑制多重耐药革兰氏阴性菌,杀菌动力学结果显示其杀菌速率显著提高,且具有较好的抗病毒效果。Compared with the prior art, the present invention provides a hyperbranched polylysine quaternary ammonium salt having a structure shown in Formula I or Formula II. The hyperbranched polylysine is quaternized to obtain a hyperbranched polylysine quaternary ammonium salt, which can not only effectively inhibit multi-drug resistant Gram-negative bacteria, but also has a significantly improved bactericidal rate as shown by the bactericidal kinetic results, and has a good antiviral effect.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为实施例2中制备的超支化聚赖氨酸季铵盐HPL-QA1的核磁氢谱图;FIG1 is a hydrogen nuclear magnetic spectrum of the hyperbranched polylysine quaternary ammonium salt HPL-QA1 prepared in Example 2;
图2为实施例2中制备的超支化聚赖氨酸季铵盐HPL-QA1处理前后大肠杆菌(左)、标准耐药大肠杆菌(中)和金黄色葡萄球菌(右)的形貌图;Figure 2 is a morphological diagram of Escherichia coli (left), standard drug-resistant Escherichia coli (middle) and Staphylococcus aureus (right) before and after treatment with the hyperbranched polylysine quaternary ammonium salt HPL-QA1 prepared in Example 2;
图3为实施例2中制备的超支化聚赖氨酸季铵盐HPL-QA1对多重耐药大肠杆菌的时间杀灭曲线;FIG3 is a time-killing curve of the hyperbranched polylysine quaternary ammonium salt HPL-QA1 prepared in Example 2 against multidrug-resistant Escherichia coli;
图4为实施例2中制备的超支化聚赖氨酸季铵盐抗H1N1病毒的效果。FIG. 4 shows the anti-H1N1 virus effect of the hyperbranched polylysine quaternary ammonium salt prepared in Example 2.
具体实施方式DETAILED DESCRIPTION
为了进一步说明本发明,下面结合实施例对本发明提供的超支化聚赖氨酸季铵盐及其制备方法和应用进行详细描述。In order to further illustrate the present invention, the hyperbranched polylysine quaternary ammonium salt provided by the present invention and its preparation method and application are described in detail below in conjunction with embodiments.
实施例1Example 1
超支化聚赖氨酸的合成Synthesis of Hyperbranched Polylysine
将90g赖氨酸盐酸盐和25g KOH加入500mL的反应瓶中,连接分水装置,抽换氮气三次,保持氮气氛围,180℃下搅拌加热反应4h,停止加热,冷却至室温,聚合物用甲醇溶解沉降到乙醚中,得到超支化聚赖氨酸(HPL)62g。通过改变反应温度和反应时间,可以获得不同分子量(1000~15000g/mol)的HPL。90g of lysine hydrochloride and 25g of KOH were added to a 500mL reaction bottle, a water separator was connected, nitrogen was replaced three times, a nitrogen atmosphere was maintained, the reaction was stirred and heated at 180°C for 4h, heating was stopped, the reaction was cooled to room temperature, the polymer was dissolved in methanol and precipitated in ether, and 62g of hyperbranched polylysine (HPL) was obtained. HPL with different molecular weights (1000-15000g/mol) can be obtained by changing the reaction temperature and reaction time.
实施例2Example 2
超支化聚赖氨酸季铵盐的合成Synthesis of Hyperbranched Polylysine Quaternary Ammonium Salt
利用小分子季铵盐,N上具有不同取代基的(2-丙烯酰胺乙基)溴化铵,(R5、R6独立地为取代或非取代的C1~C10的烷基,a为0-21的整数)与超支化聚赖氨酸通过迈克尔加成反应,制备超支化聚赖氨酸季铵盐。通过改变小分子季铵盐上烷基碳链长度(C1-C22),或R5、R6基团种类,调节超支化聚赖氨酸季铵盐的结构。通过改变小分子季铵盐与超支化聚赖氨酸的比例,调节季铵盐的接枝率,接枝率通过测定胺值进行计算。Using small molecule quaternary ammonium salts, (2-acrylamideethyl)ammonium bromide with different substituents on N, ( R 5 and R 6 are independently substituted or unsubstituted C1-C10 alkyl groups, and a is an integer of 0-21) and hyperbranched polylysine through Michael addition reaction to prepare hyperbranched polylysine quaternary ammonium salt. The structure of the hyperbranched polylysine quaternary ammonium salt is adjusted by changing the length of the alkyl carbon chain (C1-C22) on the small molecule quaternary ammonium salt, or the types of the R 5 and R 6 groups. The grafting rate of the quaternary ammonium salt is adjusted by changing the ratio of the small molecule quaternary ammonium salt to the hyperbranched polylysine, and the grafting rate is calculated by measuring the amine value.
1)将5g二甲基十二烷基(2-丙烯酰胺乙基)溴化铵溶于200mL去离子水中,加入10g的超支化聚赖氨酸,40℃下反应24h,反应混合物沉降于乙醚后,离心,得黄色固体,加水溶解后冻干,得黄色粉末状超支化聚赖氨酸季铵盐1(HPL-QA1),其核磁氢谱如图1所示。通过测定胺值计算季铵盐接枝率为20%。1) 5g dimethyldodecyl (2-acrylamideethyl) ammonium bromide Dissolved in 200 mL of deionized water, added 10 g of hyperbranched polylysine, reacted at 40 ° C for 24 h, the reaction mixture was precipitated in ether, centrifuged to obtain a yellow solid, dissolved in water and freeze-dried to obtain a yellow powdery hyperbranched polylysine quaternary ammonium salt 1 (HPL-QA1), whose nuclear magnetic hydrogen spectrum is shown in Figure 1. The quaternary ammonium salt grafting rate was calculated to be 20% by measuring the amine value.
2)依照上述1)的方法,将R5、R6基团调整为乙基、正丙基、正丁基、苄基或其他反应基团,并调节小分子季铵盐上碳链长度(C1-C22),与超支化聚赖氨酸反应,可以获得不同碳链长度的季铵盐。通过调节小分子季铵盐与超支化聚赖氨酸的比例,可以获得不同接枝率的季铵盐。具体如下表1所示:2) According to the method of 1) above, the R 5 and R 6 groups are adjusted to ethyl, n-propyl, n-butyl, benzyl or other reactive groups, and the carbon chain length (C1-C22) on the small molecule quaternary ammonium salt is adjusted, and the reaction with hyperbranched polylysine can obtain quaternary ammonium salts with different carbon chain lengths. By adjusting the ratio of the small molecule quaternary ammonium salt to the hyperbranched polylysine, quaternary ammonium salts with different grafting rates can be obtained. The details are shown in Table 1 below:
表1超支化聚赖氨酸季铵盐的合成Table 1 Synthesis of hyperbranched polylysine quaternary ammonium salt
实施例3Example 3
直接季铵化的实施例Example of direct quaternization
1)将2g实施例1制备的HPL溶解在20mL甲醇中,加入0.5g多聚甲醛和2倍当量的氰化硼氢化钠,室温反应10h,减压蒸干溶剂,加入5mL去离子水,以10mL乙酸乙酯萃取3次,合并有机相旋干得到固体,将所得固体溶于20mL DMF,再加入1g 10-溴代正癸烷和2倍当量的碳酸钾,90℃搅拌反应12h,停止加热冷却至室温,沉降于乙酸乙酯中,得到超支化聚赖氨酸季铵盐HPL-QA40。1) 2 g of HPL prepared in Example 1 was dissolved in 20 mL of methanol, 0.5 g of paraformaldehyde and 2 equivalents of sodium cyanoborohydride were added, the reaction was carried out at room temperature for 10 h, the solvent was evaporated under reduced pressure, 5 mL of deionized water was added, and the mixture was extracted 3 times with 10 mL of ethyl acetate. The organic phases were combined and dried to obtain a solid. The obtained solid was dissolved in 20 mL of DMF, 1 g of 10-bromodecane and 2 equivalents of potassium carbonate were added, the reaction was stirred at 90 ° C for 12 h, the heating was stopped and the mixture was cooled to room temperature, and the mixture was precipitated in ethyl acetate to obtain a hyperbranched polylysine quaternary ammonium salt HPL-QA40.
2)将2g HPL溶解在20mL DMF中,加入4.5g溴化苄和2g碳酸钾,120℃搅拌反应12h,再加入2g 14-碘代十四烷和2倍当量的K2CO3,90℃搅拌反应12h,停止加热冷却至室温,沉降于乙醚中,得到超支化聚赖氨酸季铵盐HPL-QA41。2) 2 g HPL was dissolved in 20 mL DMF, 4.5 g benzyl bromide and 2 g potassium carbonate were added, and the mixture was stirred at 120° C. for 12 h. 2 g 14-iodotetradecane and 2 equivalents of K 2 CO 3 were added, and the mixture was stirred at 90° C. for 12 h. The mixture was cooled to room temperature after heating was stopped, and precipitated in ether to obtain hyperbranched polylysine quaternary ammonium salt HPL-QA41.
3)将5g N(e)-Boc-L-赖氨酸与1.2g多聚甲醛和2.6g氰基硼氢化钠溶解在30mL甲醇中,室温反应12h,蒸干溶剂,加入10mL去离子水,以15mL乙酸乙酯萃取3次,合并有机相旋干,将所得产物与2倍当量的12-溴代十二烷和2倍当量的碳酸钾,90度反应12h,以正己烷/乙酸乙酯为展开剂过硅胶柱纯化得N(e)-Boc-L-赖氨酸季铵盐,用TFA/DCM混合溶液脱去BOC保护基,再与赖氨酸共聚,得超支化聚赖氨酸季铵盐45。3) 5 g of N(e)-Boc-L-lysine, 1.2 g of paraformaldehyde and 2.6 g of sodium cyanoborohydride were dissolved in 30 mL of methanol, reacted at room temperature for 12 h, the solvent was evaporated, 10 mL of deionized water was added, extracted three times with 15 mL of ethyl acetate, the organic phases were combined and spin-dried, the resulting product was reacted with 2 equivalents of 12-bromodecane and 2 equivalents of potassium carbonate at 90 degrees for 12 h, purified by silica gel column with n-hexane/ethyl acetate as developing solvent to obtain N(e)-Boc-L-lysine quaternary ammonium salt, the BOC protecting group was removed with a TFA/DCM mixed solution, and then copolymerized with lysine to obtain hyperbranched polylysine quaternary ammonium salt 45.
依照上述1)和2)的方法,通过不同反应物对氨基进行季铵化改性,可以获得不同结构的季铵盐。通过调节反应物与超支化聚赖氨酸的比例,可以获得不同接枝率的季铵盐。依照上述3)的方法,利用赖氨酸季铵盐与赖氨酸共聚可以获得不同结构的超支化聚赖氨酸季铵盐。具体如下表2所示:According to the above methods 1) and 2), quaternary ammonium salts of different structures can be obtained by quaternizing the amino group with different reactants. By adjusting the ratio of reactants to hyperbranched polylysine, quaternary ammonium salts with different grafting rates can be obtained. According to the above method 3), hyperbranched polylysine quaternary ammonium salts of different structures can be obtained by copolymerizing lysine quaternary ammonium salts with lysine. Specific examples are shown in Table 2 below:
表2.超支化聚赖氨酸季铵盐的合成Table 2. Synthesis of hyperbranched polylysine quaternary ammonium salts
对比例1超支化聚赖氨酸的合成Comparative Example 1 Synthesis of Hyperbranched Polylysine
将80g赖氨酸盐酸盐和24.5g KOH加入500mL的反应瓶中,连接分水装置,抽换氮气三次,保持氮气氛围,170℃下搅拌加热反应6h,停止加热,冷却至室温,聚合物用甲醇溶解沉降到乙醚中,得到超支化聚赖氨酸(HPL-1)51g,分子量为2600g/mol。80 g of lysine hydrochloride and 24.5 g of KOH were added to a 500 mL reaction bottle, connected to a water separator, and nitrogen was replaced three times. The nitrogen atmosphere was maintained, and the reaction was stirred and heated at 170 ° C for 6 h. The heating was stopped and cooled to room temperature. The polymer was dissolved in methanol and precipitated in ether to obtain 51 g of hyperbranched polylysine (HPL-1) with a molecular weight of 2600 g/mol.
对比例2α-聚赖氨酸季铵盐的合成Comparative Example 2 Synthesis of α-polylysine quaternary ammonium salt
反应瓶中加入溶解了ε-苄氧羰基-L-赖氨酸-N-羧基-环内酸酐(ZLL-NCA)的无水DMSO-二氯甲烷混合溶液,加入引发剂丙胺引发开环聚合,再以TFA/HBr进行脱保护,透析,冷冻干燥,得α-聚赖氨酸,将2gα-聚赖氨酸与0.5g二甲基十二烷基(2-丙烯酰胺乙基)溴化铵溶于10mL去离子水中,40℃下反应24h,反应混合物沉降于乙醚后,离心,得淡黄色固体α-聚赖氨酸季铵盐(αPL-QA)。Anhydrous DMSO-dichloromethane mixed solution in which ε-benzyloxycarbonyl-L-lysine-N-carboxyl-cyclic anhydride (ZLL-NCA) was dissolved was added to the reaction flask, and the initiator propylamine was added to initiate the ring-opening polymerization, and then deprotected with TFA/HBr, dialyzed, and freeze-dried to obtain α-polylysine. 2g of α-polylysine was mixed with 0.5g of dimethyldodecyl (2-acrylamideethyl) ammonium bromide. The product was dissolved in 10 mL of deionized water and reacted at 40 °C for 24 h. The reaction mixture was precipitated in ether and centrifuged to obtain a light yellow solid α-polylysine quaternary ammonium salt (αPL-QA).
实施例4抗菌性能测试Example 4 Antibacterial Performance Test
最小抑菌浓度(MIC99)(完全抑制99%微生物生长需要的聚合物最低浓度)测试:Minimum inhibitory concentration (MIC 99 ) (the lowest concentration of polymer required to completely inhibit 99% microbial growth) test:
以下实施例中所用到的各种标准菌株购自上海鲁微科技有限公司,临床多重耐药菌株来自吉林大学白求恩第一医院。The various standard strains used in the following examples were purchased from Shanghai Luwei Technology Co., Ltd., and the clinical multidrug-resistant strains were from the Bethune First Hospital of Jilin University.
分别取实施例2-3制备的超支化聚赖氨酸季铵盐和对比例1中制备的超支化聚赖氨酸、对比例2中制备的α-聚赖氨酸季铵盐,采用二倍稀释法配制浓度分别为12,6,3,1.5,0.75,0.375,0.188,0.094,0.048,0.024mg/mL的10个不同浓度梯度的聚合物溶液。The hyperbranched polylysine quaternary ammonium salt prepared in Examples 2-3, the hyperbranched polylysine prepared in Comparative Example 1, and the α-polylysine quaternary ammonium salt prepared in Comparative Example 2 were respectively taken, and 10 polymer solutions with different concentration gradients of 12, 6, 3, 1.5, 0.75, 0.375, 0.188, 0.094, 0.048, and 0.024 mg/mL were prepared by a two-fold dilution method.
参照美国临床和实验室标准协会(CLSI)抗菌药物敏感性试验标准M07-A9中所描述的肉汤稀释法进行聚合物的抗细菌性能测试。The antibacterial performance of the polymer was tested according to the broth dilution method described in the American Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility test standard M07-A9.
细菌增长率(%)=(A样品-A阴性对照)/(A阳性对照-A阴性对照)×100Bacterial growth rate (%) = (A sample - A negative control ) / (A positive control - A negative control ) × 100
其中,A样品、A阴性对照、A阳性对照分别表示聚合物实验组、阴性对照组和阳性对照组在600nm处的吸光度值。最小抑菌浓度(MIC99)定义为与对照组相比,完全抑制99%微生物生长需要的聚合物最低浓度。Wherein, A sample , A negative control , A positive control represent the absorbance values of polymer experimental group, negative control group and positive control group at 600nm respectively. Minimum inhibitory concentration (MIC 99 ) is defined as the lowest concentration of polymer required to completely inhibit 99% microbial growth compared with the control group.
最小抑菌浓度(MIC99)结果如下表3所示:The minimum inhibitory concentration (MIC 99 ) results are shown in Table 3 below:
表3不同抗菌聚合物对不同细菌的MIC值的比较Table 3 Comparison of MIC values of different antimicrobial polymers against different bacteria
图2为HPL-QA1抗大肠杆菌(左)、耐药大肠杆菌(中)和金黄色葡萄球菌(右)处理前(上)与处理后(下)的SEM图像,可以看出,未经聚合物处理的大肠杆菌及耐药大肠杆菌的形态均为均匀的杆状,金黄色葡萄球菌为球形,均具有完整的表面且大量存在。而经过HPL-1或HPL-QA1处理后的大肠杆菌、耐药大肠杆菌和金黄色葡萄球菌均表现出了较为明显的形态改变。经过聚合物处理后的大肠杆菌和耐药大肠杆菌均表面出现了明显的塌陷、皱缩及孔洞,表明其细胞膜已经受到严重的损伤;经过聚合物处理后的金黄色葡萄球菌,表面不再光滑,出现了皱缩、凹陷的情况,同样显示其细胞膜完整性被破坏。Figure 2 shows the SEM images of HPL-QA1 anti-E. coli (left), resistant E. coli (middle) and Staphylococcus aureus (right) before (top) and after (bottom) treatment. It can be seen that the morphology of E. coli and resistant E. coli without polymer treatment is uniform rod-shaped, and Staphylococcus aureus is spherical, all with complete surfaces and in large quantities. After being treated with HPL-1 or HPL-QA1, E. coli, resistant E. coli and Staphylococcus aureus all showed obvious morphological changes. E. coli and resistant E. coli treated with polymers showed obvious collapse, shrinkage and holes on the surface, indicating that their cell membranes have been severely damaged; after being treated with polymers, the surface of Staphylococcus aureus is no longer smooth, and wrinkles and depressions appear, which also shows that the integrity of its cell membrane has been destroyed.
实施例5杀菌速度检测Example 5 Sterilization Speed Detection
按照《消毒技术规范》(2002版)2.1.1.7悬液定量杀灭试验方法操作,在无菌试管内加入0.5ml试验用菌悬液与0.5mL有机干扰物质,再加入4.0ml抗菌聚合物溶液(100μg/mL)(阳性对照用PBS),充分混匀。作用至预定时间,吸取0.5ml样液加于4.5ml经灭菌的中和剂中,混匀。中和作用10min,取样液1.0ml接种培养,按活菌培养计数方法测定存活菌数,计算平均杀灭对数值,试验重复3次。According to the suspension quantitative killing test method in 2.1.1.7 of the "Technical Specifications for Disinfection" (2002 Edition), add 0.5ml of the test bacterial suspension and 0.5mL of organic interfering substances into a sterile test tube, then add 4.0ml of antibacterial polymer solution (100μg/mL) (PBS for positive control), and mix thoroughly. After the action reaches the predetermined time, take 0.5ml of the sample solution and add it to 4.5ml of the sterilized neutralizer, and mix well. After the neutralization action for 10 minutes, 1.0ml of the sample solution was inoculated and cultured, and the number of surviving bacteria was determined by the live bacteria culture counting method, and the average killing logarithm was calculated. The test was repeated 3 times.
实施例2中制备的HPL-QA1和对比例1中制备的HPL-1、对比例2中制备的αPL-QA的杀菌速度检测结果如下表4所示:The sterilization speed test results of HPL-QA1 prepared in Example 2, HPL-1 prepared in Comparative Example 1, and αPL-QA prepared in Comparative Example 2 are shown in Table 4 below:
表4Table 4
实施例6Example 6
在培养基中细菌杀灭率的测试Test of bacterial killing rate in culture medium
使用大肠杆菌(E.coli)、标准耐药大肠杆菌(EIEC)、临床分离的多重耐药大肠杆菌(E1)测试了材料的杀菌动力学。使用LB肉汤培养基将细菌在37℃下培养至对数生长中期,使用PBS缓冲液进行三次洗涤。将菌液在新鲜的MH肉汤培养基中稀释至106CFU/mL,加入100μL聚合物溶液处理并保证其浓度为24μg/mL(1×MIC99)。使用100μL PBS溶液处理作为对照。分别在处理后的0,0.5,1,2,3,4,5,6小时取20μL混合液使用PBS稀释至合适浓度,然后取100μL在LB平板上涂布均匀,在37℃培养箱中孵育24小时后统计菌落数目。The bactericidal kinetics of the material were tested using Escherichia coli (E.coli), standard drug-resistant E.coli (EIEC), and clinically isolated multidrug-resistant E.coli (E1). The bacteria were cultured at 37°C to mid-logarithmic growth using LB broth medium and washed three times with PBS buffer. The bacterial solution was diluted to 10 6 CFU/mL in fresh MH broth medium, and 100 μL of polymer solution was added to ensure that its concentration was 24 μg/mL (1×MIC 99 ). 100 μL of PBS solution was used as a control. 20 μL of the mixed solution was diluted to the appropriate concentration using PBS at 0, 0.5, 1, 2, 3, 4, 5, and 6 hours after treatment, and then 100 μL was evenly spread on the LB plate, and the number of colonies was counted after incubation in a 37°C incubator for 24 hours.
结果如图3所示,HPL-1在6小时的作用时间内只能使E.coli、EIEC、E1的浓度降低2个数量级,而HPL-QA1在3小时的作用时间内使培养基中细菌的浓度降低6个数量级,对E.coli、EIEC、E1实现完全杀灭的效果。The results are shown in Figure 3. HPL-1 can only reduce the concentration of E. coli, EIEC, and E1 by 2 orders of magnitude within 6 hours of action, while HPL-QA1 can reduce the concentration of bacteria in the culture medium by 6 orders of magnitude within 3 hours of action, achieving a complete killing effect on E. coli, EIEC, and E1.
实施例7抗病毒性能测试Example 7 Antiviral Performance Test
使用甲型流感病毒H1N1:A/PR/8/34(ATCC VR-1469)按照《消毒技术规范》(2002版)中的方法测试材料的抗病毒性能。具体方法如下:将病毒接种于长满单层MDCK细胞的细胞瓶中,在37℃下培养,待75%细胞出现病变时收获病毒。取100μL 3%牛血清白蛋白与100μL病毒原液混合,于20±1℃水浴中作用5分钟,然后加入0.8mL聚合物溶液,立即计时。作用2小时后立即取出0.1mL,加入中和剂混匀。使用去离子水代替聚合物溶液作为阳性对照。使用终点稀释法测定病毒滴度。用细胞维持培养液对样本进行10倍的系列稀释,在含有宿主细胞的96孔板中滴定不同稀释度的样本,在37℃条件下放置1-2小时,确保残留病毒全部吸附在细胞上。更换细胞维持培养液,继续放入二氧化碳培养箱中(37℃,5% CO2)培养,在显微镜下观察细胞病变,连续观察3天并记录细胞病变情况。以半数细胞感染剂(TCID50)表示病毒感染滴度。平均灭活对数值按下式计算:The antiviral performance of the material was tested using influenza virus H1N1: A/PR/8/34 (ATCC VR-1469) according to the method in the "Technical Specifications for Disinfection" (2002 edition). The specific method is as follows: the virus was inoculated into a cell bottle covered with a monolayer of MDCK cells, cultured at 37°C, and the virus was harvested when 75% of the cells showed pathological changes. 100μL of 3% bovine serum albumin was mixed with 100μL of virus stock solution, and it was placed in a 20±1°C water bath for 5 minutes, and then 0.8mL of polymer solution was added and the time was immediately started. After 2 hours of action, 0.1mL was immediately taken out and mixed with a neutralizer. Deionized water was used instead of polymer solution as a positive control. The virus titer was determined using the endpoint dilution method. The sample was serially diluted 10 times with cell maintenance culture medium, and samples of different dilutions were titrated in a 96-well plate containing host cells, and placed at 37°C for 1-2 hours to ensure that all residual viruses were adsorbed on the cells. Replace the cell maintenance medium and continue to culture in a carbon dioxide incubator (37°C, 5% CO 2 ). Observe the cytopathic effect under a microscope for 3 consecutive days and record the cytopathic effect. The virus infection titer is expressed as half of the cell infection agent (TCID 50 ). The average logarithmic inactivation value is calculated as follows:
平均灭活对数值=logN0-logNx Average logarithmic inactivation value = logN 0 -logN x
其中,N0为阳性对照组平均病毒感染滴度(TCID50),Nx为试验组平均病毒感染滴度(TCID50)。Wherein, N0 is the average virus infection titer ( TCID50 ) of the positive control group, and Nx is the average virus infection titer ( TCID50 ) of the test group.
抗菌聚合物在100μg/mL的浓度下经过2小时的处理对甲型流感病毒H1N1的杀灭效果如图4所示,HPL-1对病毒无杀灭作用,超支化聚赖氨酸季铵盐对H1N1病毒具有较好的杀灭效果,病毒杀灭率达到89.8%-99.99%。The killing effect of the antibacterial polymer on influenza A virus H1N1 after 2 hours of treatment at a concentration of 100 μg/mL is shown in Figure 4. HPL-1 has no killing effect on the virus, and the hyperbranched polylysine quaternary ammonium salt has a good killing effect on the H1N1 virus, with a virus killing rate of 89.8%-99.99%.
上述抗菌试验表明,本发明提供的超支化聚赖氨酸季铵盐可有效抑制多重耐药革兰氏阴性菌,且具有最小抑菌浓度低,杀菌速度快的特点,为对抗多重耐药菌感染带来了新的治疗手段。The above antibacterial test shows that the hyperbranched polylysine quaternary ammonium salt provided by the present invention can effectively inhibit multidrug-resistant Gram-negative bacteria, and has the characteristics of low minimum inhibitory concentration and fast bactericidal speed, which provides a new treatment method for combating multidrug-resistant bacterial infection.
以上实施例的说明只是用于帮助理解本发明的方法及其核心思想。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以对本发明进行若干改进和修饰,这些改进和修饰也落入本发明权利要求的保护范围内。The above embodiments are only used to help understand the method and core idea of the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principles of the present invention, and these improvements and modifications also fall within the scope of protection of the claims of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310986434.2A CN117004036A (en) | 2023-08-07 | 2023-08-07 | A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310986434.2A CN117004036A (en) | 2023-08-07 | 2023-08-07 | A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117004036A true CN117004036A (en) | 2023-11-07 |
Family
ID=88575848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310986434.2A Pending CN117004036A (en) | 2023-08-07 | 2023-08-07 | A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117004036A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118846183A (en) * | 2024-07-04 | 2024-10-29 | 浙江奥奇医用敷料有限公司 | Preparation method of sodium alginate composite fiber membrane antibacterial dressing |
| CN119613709A (en) * | 2024-12-09 | 2025-03-14 | 中国科学院长春应用化学研究所 | Hyperbranched polylysine with high epsilon-linear units and preparation method and application thereof |
| CN119970703A (en) * | 2025-01-10 | 2025-05-13 | 中国科学院长春应用化学研究所 | Application of quaternized hyperbranched polylysine in the preparation of drugs for preventing and treating superficial fungal infections |
-
2023
- 2023-08-07 CN CN202310986434.2A patent/CN117004036A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118846183A (en) * | 2024-07-04 | 2024-10-29 | 浙江奥奇医用敷料有限公司 | Preparation method of sodium alginate composite fiber membrane antibacterial dressing |
| CN118846183B (en) * | 2024-07-04 | 2025-03-11 | 浙江奥奇医用敷料有限公司 | Preparation method of sodium alginate composite fiber membrane antibacterial dressing |
| CN119613709A (en) * | 2024-12-09 | 2025-03-14 | 中国科学院长春应用化学研究所 | Hyperbranched polylysine with high epsilon-linear units and preparation method and application thereof |
| CN119613709B (en) * | 2024-12-09 | 2025-06-17 | 中国科学院长春应用化学研究所 | Hyperbranched polylysine with high content of ε-linear units and preparation method and application thereof |
| CN119970703A (en) * | 2025-01-10 | 2025-05-13 | 中国科学院长春应用化学研究所 | Application of quaternized hyperbranched polylysine in the preparation of drugs for preventing and treating superficial fungal infections |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN117004036A (en) | A kind of hyperbranched polylysine quaternary ammonium salt and its preparation method and application | |
| Fang et al. | Antibacterial activities of N-alkyl imidazolium-based poly (ionic liquid) nanoparticles | |
| Pham et al. | Effect of hydrophilic groups on the bioactivity of antimicrobial polymers | |
| CN106750262B (en) | The synthesis of amphipathic block antibacterial peptide and its preparation method and application of assembly | |
| CN108329467B (en) | A kind of preparation method of hyperbranched antimicrobial peptide polymer | |
| CN107619475B (en) | Antibacterial peptide containing dopamine adhesion group and preparation method and application thereof | |
| CN110437374A (en) | A kind of amphipathic cationic polymer of quaternary ammonium salt and its application | |
| CN107513145A (en) | The synthesis of biodegradable amphiphilic block class antibacterial peptide and the preparation method and application of class antibacterial peptide vesica | |
| Wu et al. | Acidity-triggered charge-reversible multilayers for construction of adaptive surfaces with switchable bactericidal and bacteria-repelling functions | |
| Wang et al. | Preparation of water dispersible poly (methyl methacrylate)-based vesicles for facile persistent antibacterial applications | |
| CN107459654A (en) | One kind simulation antibacterial peptide copolymer and preparation method thereof | |
| CN102702451B (en) | High-efficiency and antibacterial polymeric micelle with high pH sensibility and biocompatibility and preparation method thereof | |
| CN113430719B (en) | A kind of preparation method of air filtration nanofiber membrane with dendritic multilevel structure | |
| CN118344525A (en) | Sulfur-containing polymer and application thereof in preparation of antibacterial drugs | |
| JP4476807B2 (en) | Poly (potassium and sodium styrenesulfonate), its manufacture and its use | |
| CN105001198B (en) | Macromolecule disinfection sanitizer of the functional group of quaternary ammonium salt containing pyridines and preparation method thereof | |
| WO2004046109A2 (en) | Ionene oligomers and polymers | |
| CN112876682B (en) | A kind of quaternary ammonium salt polysulfone antibacterial liquid, preparation method and application thereof | |
| CN119241837A (en) | A cyclic cationic polyamino acid, preparation method and application thereof | |
| CN113956503A (en) | Polycation nano antibacterial agent, preparation method and application thereof | |
| WO2023279594A1 (en) | Homopolymer electrolyte composite vesicle, preparation method therefor, antibacterial vesicle, vesicle containing hydrophobic substances and anti-adhesion vesicle | |
| CN117447663B (en) | Porphyrin-based conjugated organic framework material based on membrane-penetrating peptide modification, and preparation method and application thereof | |
| CN115444965B (en) | Cyclic peptide antibacterial nano dressing and preparation method thereof | |
| CN112293416A (en) | Environment-friendly non-release CS-b-PEG (polyethylene glycol) antibacterial micelle and preparation method thereof | |
| CN114052318B (en) | Mask with drug-resistant bacteria resisting function and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |